Vaxdigm

Developer of vaccines and immunotherapies for infectious disease

placeSeoul, Seoul, South Korea calendar_todayFounded 2021 groups9 employees language vaxdigm.com

Investor mix

6 investors on record; lead investors include LITALCO, Korea Alternative Investment, The Invention Lab, New Paradigm Investment.

Investor typeCountShare
Venture capital233%
Accelerator & incubator233%
Other / undisclosed233%
Coming soon